In vitro and in vivo evaluation of pectin beads for the colon delivery of β-lactamases

被引:31
作者
Bourgeois, S
Laham, A
Besnard, M
Andremont, A
Fattal, E
机构
[1] Univ Paris Sud, Grp Targeting & Delivery Poorly Stable Cpds, CNRS, UMR 8612,Sch Pharm, F-92296 Chatenay Malabry, France
[2] Sch Pharm, Pharmaceut Technol Lab, Damascus, Syria
[3] Hosp Bichat Claude Bernard, Microbiol Lab, Paris, France
关键词
pectin beads; beta lactamase; colon delivery; beta lactams; antibiotic resistances;
D O I
10.1080/10611860500206583
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present study was to provide a "proof of concept" of colon delivery of beta-lactamases by pectin beads aiming to degrade residual beta-lactam antibiotics, in order to prevent the emergence of resistant bacterial strains. Pectin beads were prepared according to ionotropic gelation method using CaCl2 as a gelling agent. Particles were then washed and soaked in polyethylenimine (PEI). Coating beads with PEI considerably improved their stability in simulated intestinal medium. In vitro studies showed that beta-lactamases were released from pectin beads in colonic medium due to the action of pectinolytic enzymes. When ampicillin was added to this medium, the release of beta-lactamases induced, as expected, the antibiotic inactivation. Finally, after oral administration of loaded-beads to CD1 mice, beta-lactamases were retrieved in high concentrations in faeces. Observation by SEM of beads extracted from mice intestinal tracts concluded the core degradation of beads without any modification of the PEI coating layer. This study demonstrates that a multiparticulate system with suitable characteristics for site-specific colonic delivery can be prepared. This system could be used to target beta-lactamases to the colon in order to hydrolyse antibiotic residues during treatment and prevent their impact on colonic microflora.
引用
收藏
页码:277 / 284
页数:8
相关论文
共 38 条
[1]   COLONIC TRANSIT OF DIFFERENT SIZED TABLETS IN HEALTHY-SUBJECTS [J].
ADKIN, DA ;
DAVIS, SS ;
SPARROW, RA ;
WILDING, IR .
JOURNAL OF CONTROLLED RELEASE, 1993, 23 (02) :147-156
[2]  
Andremont A, 2000, ANN FR ANESTH, V19, P395
[3]   CEFTRIAXONE - RENAL AND BILIARY-EXCRETION AND EFFECT ON THE COLON MICROFLORA [J].
ARVIDSSON, A ;
ALVAN, G ;
ANGELIN, B ;
BORGA, O ;
NORD, CE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 10 (03) :207-215
[4]   ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITIS DUE TO TOXIN-PRODUCING CLOSTRIDIA [J].
BARTLETT, JG ;
CHANG, TW ;
GURWITH, M ;
GORBACH, SL ;
ONDERDONK, AB .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (10) :531-534
[5]   Enteric bacteria: Friend or foe? [J].
Batt, RM ;
Rutgers, HC ;
Sancak, AA .
JOURNAL OF SMALL ANIMAL PRACTICE, 1996, 37 (06) :261-267
[6]   A theoretical model of erosion and macromolecular drug release from biodegrading microspheres [J].
Batycky, RP ;
Hanes, J ;
Langer, R ;
Edwards, DA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (12) :1464-1477
[7]  
BOURGEOIS S, 2003, Patent No. 0302474
[8]   SHEDDING OF CLOSTRIDIUM-DIFFICILE, FECAL BETA-LACTAMASE ACTIVITY, AND GASTROINTESTINAL SYMPTOMS IN 51 VOLUNTEERS TREATED WITH ORAL CEFIXIME [J].
CHACHATY, E ;
BOURNEIX, C ;
RENARD, S ;
BONNAY, M ;
ANDREMONT, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (07) :1432-1435
[9]   PRESENCE OF CLOSTRIDIUM-DIFFICILE AND ANTIBIOTIC AND BETA-LACTAMASE ACTIVITIES IN FECES OF VOLUNTEERS TREATED WITH ORAL CEFIXIME, ORAL CEFPODOXIME PROXETIL, OR PLACEBO [J].
CHACHATY, E ;
DEPITRE, C ;
MARIO, N ;
BOURNEIX, C ;
SAULNIER, P ;
CORTHIER, G ;
ANDREMONT, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) :2009-2013
[10]   ANTIBIOTIC RESIDUES AND DRUG-RESISTANCE IN HUMAN INTESTINAL FLORA [J].
CORPET, DE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (04) :587-593